series-c-plus
Stage
2017
Founded
3
Investors
About
Ideaya Biosciences is a clinical-stage precision oncology company that discovers and develops therapies targeting DNA damage response (DDR) pathways and exploiting synthetic lethality, and develops predictive biomarkers to guide patient selection.
Explore Ideaya Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.